R&D | April 17, 2026
Revvity aims to accelerate breakthroughs in cancer research
Revvity is positioning its technologies as a connected engine for discovery
Revvity is positioning its technologies as a connected engine for discovery
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
A major push to sharpen the future of cancer treatment is underway
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Subscribe To Our Newsletter & Stay Updated
